![]()
Imported Disease Annotations - OMIMObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ASTL | Human | Oocyte/Zygote/Embryo Maturation Arrest 11 | | IAGP | | 7240710 | | OMIM | | |
|
![]()
Imported Disease Annotations - OMIMObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ASTL | Human | Oocyte/Zygote/Embryo Maturation Arrest 11 | | IAGP | | 7240710 | | OMIM | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:12477932 | PMID:19913121 | PMID:20628086 | PMID:21873635 | PMID:22206759 | PMID:22472438 | PMID:24038607 | PMID:26186194 | PMID:26327203 | PMID:28514442 | PMID:30862715 | PMID:32296183 |
PMID:33629311 | PMID:33961781 | PMID:34704130 |
ASTL (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Astl (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Astl (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Astl (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ASTL (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ASTL (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Astl (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ASTL (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ASTL (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Astl (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in ASTL
48 total Variants ![]() |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 2q11.1-11.2(chr2:95879602-97029672)x3 | copy number gain | Global developmental delay [RCV000050366]|See cases [RCV000050366] | Chr2:95879602..97029672 [GRCh38] Chr2:96545350..97695409 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh38/hg38 2q11.1-11.2(chr2:95879602-97285797)x1 | copy number loss | See cases [RCV000051260] | Chr2:95879602..97285797 [GRCh38] Chr2:96545350..98013866 [GRCh37] Chr2:95909077..97380005 [NCBI36] Chr2:2q11.1-11.2 |
pathogenic |
GRCh38/hg38 2q11.2(chr2:96100812-97285797)x1 | copy number loss | See cases [RCV000051137] | Chr2:96100812..97285797 [GRCh38] Chr2:96766560..98013866 [GRCh37] Chr2:96130287..97380005 [NCBI36] Chr2:2q11.2 |
pathogenic |
GRCh38/hg38 2q11.1-11.2(chr2:95806265-97285797)x3 | copy number gain | See cases [RCV000053136] | Chr2:95806265..97285797 [GRCh38] Chr2:96472013..98013866 [GRCh37] Chr2:95835740..97380005 [NCBI36] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh38/hg38 2q11.2(chr2:96100612-97285797)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053140]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053140]|See cases [RCV000053140] | Chr2:96100612..97285797 [GRCh38] Chr2:96766360..98014007 [GRCh37] Chr2:96130087..97380146 [NCBI36] Chr2:2q11.2 |
uncertain significance |
GRCh38/hg38 2q11.1-12.1(chr2:94817406-103252396)x3 | copy number gain | See cases [RCV000052946] | Chr2:94817406..103252396 [GRCh38] Chr2:95618109..103868854 [GRCh37] Chr2:94846878..103235286 [NCBI36] Chr2:2q11.1-12.1 |
pathogenic |
GRCh38/hg38 2p11.2-q11.2(chr2:91443218-102334856)x3 | copy number gain | See cases [RCV000052945] | Chr2:91443218..102334856 [GRCh38] Chr2:91617683..102951316 [GRCh37] Chr2:90981410..102317748 [NCBI36] Chr2:2p11.2-q11.2 |
pathogenic |
Single allele | deletion | Intellectual disability [RCV001293378] | Chr2:96737083..98193473 [GRCh37] Chr2:2q11.1-11.2 |
pathogenic |
GRCh38/hg38 2q11.1-11.2(chr2:95810453-97024341)x3 | copy number gain | See cases [RCV000053137] | Chr2:95810453..97024341 [GRCh38] Chr2:96476201..97690078 [GRCh37] Chr2:95839928..97053805 [NCBI36] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh38/hg38 2q11.1-11.2(chr2:95880668-97131646)x3 | copy number gain | See cases [RCV000053138] | Chr2:95880668..97131646 [GRCh38] Chr2:96546416..97797383 [GRCh37] Chr2:95910143..97161110 [NCBI36] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh38/hg38 2q11.1-11.2(chr2:95916534-97024341)x3 | copy number gain | See cases [RCV000053139] | Chr2:95916534..97024341 [GRCh38] Chr2:96582282..97690078 [GRCh37] Chr2:95946009..97053805 [NCBI36] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh38/hg38 2q11.1-11.2(chr2:95493468-96977610)x3 | copy number gain | See cases [RCV000133839] | Chr2:95493468..96977610 [GRCh38] Chr2:96159216..97643347 [GRCh37] Chr2:95522943..97007074 [NCBI36] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh38/hg38 2q11.1-11.2(chr2:95879602-97029672)x3 | copy number gain | See cases [RCV000050366] | Chr2:95879602..97029672 [GRCh38] Chr2:96545350..97695409 [GRCh37] Chr2:95909077..97059136 [NCBI36] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh38/hg38 2q11.1-11.2(chr2:95879602-97029672)x1 | copy number loss | See cases [RCV000134141] | Chr2:95879602..97029672 [GRCh38] Chr2:96545350..97695409 [GRCh37] Chr2:95909077..97059136 [NCBI36] Chr2:2q11.1-11.2 |
pathogenic |
GRCh38/hg38 2q11.2(chr2:96073560-97062710)x1 | copy number loss | See cases [RCV000135343] | Chr2:96073560..97062710 [GRCh38] Chr2:96739308..97728447 [GRCh37] Chr2:96103035..97092174 [NCBI36] Chr2:2q11.2 |
pathogenic |
GRCh38/hg38 2q11.2(chr2:96100812-97154835)x1 | copy number loss | See cases [RCV000137012] | Chr2:96100812..97154835 [GRCh38] Chr2:96766560..97820572 [GRCh37] Chr2:96130287..97184299 [NCBI36] Chr2:2q11.2 |
uncertain significance |
GRCh38/hg38 2q11.1-11.2(chr2:95766541-97589743)x3 | copy number gain | See cases [RCV000137817] | Chr2:95766541..97589743 [GRCh38] Chr2:96432289..98206206 [GRCh37] Chr2:95796016..97572638 [NCBI36] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh38/hg38 2q11.1-13(chr2:94678532-110602409)x3 | copy number gain | See cases [RCV000141075] | Chr2:94678532..110602409 [GRCh38] Chr2:95344257..111359986 [GRCh37] Chr2:94707984..111076455 [NCBI36] Chr2:2q11.1-13 |
pathogenic |
GRCh38/hg38 2q11.2(chr2:96066771-97285797)x3 | copy number gain | See cases [RCV000142146] | Chr2:96066771..97285797 [GRCh38] Chr2:96732519..98079569 [GRCh37] Chr2:96096246..97432433 [NCBI36] Chr2:2q11.2 |
uncertain significance |
GRCh38/hg38 2q11.2(chr2:96100816-97285797)x3 | copy number gain | See cases [RCV000142814] | Chr2:96100816..97285797 [GRCh38] Chr2:96766564..98013954 [GRCh37] Chr2:96130291..97380093 [NCBI36] Chr2:2q11.2 |
uncertain significance |
GRCh38/hg38 2q11.1-11.2(chr2:95337458-99072953)x3 | copy number gain | See cases [RCV000138012] | Chr2:95337458..99072953 [GRCh38] Chr2:96003206..99689416 [GRCh37] Chr2:95366933..99055848 [NCBI36] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh38/hg38 2q11.2(chr2:96073560-97513144)x1 | copy number loss | See cases [RCV000142800] | Chr2:96073560..97513144 [GRCh38] Chr2:96739308..98066294 [GRCh37] Chr2:96103035..97496039 [NCBI36] Chr2:2q11.2 |
pathogenic |
GRCh37/hg19 2p25.3-q37.3(chr2:14238-243048760)x3 | copy number gain | not provided [RCV000752802] | Chr2:14238..243048760 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2q11.1-12.3(chr2:95529039-108518266) | copy number gain | See cases [RCV000449270] | Chr2:95529039..108518266 [GRCh37] Chr2:2q11.1-12.3 |
pathogenic |
GRCh37/hg19 2q11.1-13(chr2:95327499-111370025)x4 | copy number gain | See cases [RCV000446842] | Chr2:95327499..111370025 [GRCh37] Chr2:2q11.1-13 |
pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96698012-97757442)x3 | copy number gain | See cases [RCV000445685] | Chr2:96698012..97757442 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:95691600-100587394) | copy number gain | See cases [RCV000447723] | Chr2:95691600..100587394 [GRCh37] Chr2:2q11.1-11.2 |
pathogenic |
NC_000002.11:g.(?_96738407)_(97742073_?)del | deletion | Schizophrenia [RCV000416822] | Chr2:96738407..97742073 [GRCh37] Chr2:96102134..97105800 [NCBI36] Chr2:2q11.1-11.2 |
likely pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96778661-97757978)x3 | copy number gain | See cases [RCV000448583] | Chr2:96778661..97757978 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384) | copy number gain | See cases [RCV000512056] | Chr2:12771..242783384 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96468158-97871906)x3 | copy number gain | See cases [RCV000511375] | Chr2:96468158..97871906 [GRCh37] Chr2:2q11.1-11.2 |
likely pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96097383-97679933)x1 | copy number loss | See cases [RCV000511715] | Chr2:96097383..97679933 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:96732519-98225552)x3 | copy number gain | See cases [RCV000511635] | Chr2:96732519..98225552 [GRCh37] Chr2:2q11.1-11.2 |
likely benign |
GRCh37/hg19 2q11.1-11.2(chr2:96712139-98249638)x1 | copy number loss | See cases [RCV000511596] | Chr2:96712139..98249638 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-12.2(chr2:95518497-107186127) | copy number gain | See cases [RCV000511158] | Chr2:95518497..107186127 [GRCh37] Chr2:2q11.1-12.2 |
uncertain significance |
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)x3 | copy number gain | See cases [RCV000511212] | Chr2:12771..242783384 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
NM_001002036.4(ASTL):c.1274T>A (p.Phe425Tyr) | single nucleotide variant | not specified [RCV004313390] | Chr2:96123872 [GRCh38] Chr2:96789611 [GRCh37] Chr2:2q11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:96735977-98258828)x1 | copy number loss | not provided [RCV000682130] | Chr2:96735977..98258828 [GRCh37] Chr2:2q11.1-11.2 |
likely pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96544602-98138405)x1 | copy number loss | not provided [RCV000682132] | Chr2:96544602..98138405 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-13(chr2:96353030-114045463)x3 | copy number gain | not provided [RCV000682168] | Chr2:96353030..114045463 [GRCh37] Chr2:2q11.1-13 |
pathogenic |
Single allele | deletion | not provided [RCV000714264] | Chr2:40608411..146900718 [GRCh37] Chr2:2p22.1-q22.3 |
likely pathogenic |
NC_000002.12:g.(?_96063558)_(97079140_?)del | deletion | Schizophrenia [RCV000754268] | Chr2:96063558..97079140 [GRCh38] Chr2:2q11.2 |
likely pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96747466-98193473)x1 | copy number loss | See cases [RCV000790587] | Chr2:96747466..98193473 [GRCh37] Chr2:2q11.1-11.2 |
likely pathogenic |
NC_000002.11:g.(?_96780545)_(96971175_?)dup | duplication | not provided [RCV001031839] | Chr2:96780545..96971175 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
NC_000002.11:g.(?_96780545)_(96994037_?)dup | duplication | not provided [RCV001031880] | Chr2:96780545..96994037 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.465G>A (p.Ser155=) | single nucleotide variant | not provided [RCV000879722] | Chr2:96132712 [GRCh38] Chr2:96798451 [GRCh37] Chr2:2q11.2 |
benign |
NM_001002036.4(ASTL):c.1282del (p.Met428fs) | deletion | not provided [RCV000961967] | Chr2:96123864 [GRCh38] Chr2:96789603 [GRCh37] Chr2:2q11.2 |
benign |
GRCh37/hg19 2q11.1-11.2(chr2:96712139-98254657)x1 | copy number loss | not provided [RCV001005295] | Chr2:96712139..98254657 [GRCh37] Chr2:2q11.1-11.2 |
likely pathogenic|uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:96515883-98025634)x3 | copy number gain | not provided [RCV000845755] | Chr2:96515883..98025634 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:96552903-98118115)x1 | copy number loss | not provided [RCV000848564] | Chr2:96552903..98118115 [GRCh37] Chr2:2q11.1-11.2 |
pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96732519-98118115)x3 | copy number gain | not provided [RCV001005296] | Chr2:96732519..98118115 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.872G>A (p.Arg291Lys) | single nucleotide variant | not provided [RCV000974919] | Chr2:96129826 [GRCh38] Chr2:96795565 [GRCh37] Chr2:2q11.2 |
benign |
GRCh37/hg19 2q11.1-11.2(chr2:95341388-100340514)x3 | copy number gain | not provided [RCV002473932] | Chr2:95341388..100340514 [GRCh37] Chr2:2q11.1-11.2 |
likely pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96737083-98261802)x1 | copy number loss | See cases [RCV001194515] | Chr2:96737083..98261802 [GRCh37] Chr2:2q11.1-11.2 |
likely pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96737083-98193473)x3 | copy number gain | See cases [RCV001194576] | Chr2:96737083..98193473 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:96515883-98162176)x3 | copy number gain | not provided [RCV001259641] | Chr2:96515883..98162176 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:96421161-97765561)x1 | copy number loss | not provided [RCV001259642] | Chr2:96421161..97765561 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2p25.3-q37.3(chr2:1-243199373) | copy number gain | Mosaic trisomy 2 [RCV002280628] | Chr2:1..243199373 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96630256-96836549)x3 | copy number gain | not provided [RCV001259640] | Chr2:96630256..96836549 [GRCh37] Chr2:2q11.1-11.2 |
likely benign |
GRCh37/hg19 2q11.1-11.2(chr2:96755045-98021592) | copy number loss | Fetal growth restriction [RCV001352673] | Chr2:96755045..98021592 [GRCh37] Chr2:2q11.1-11.2 |
pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96544603-98025634)x3 | copy number gain | not provided [RCV001832989] | Chr2:96544603..98025634 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.456-1G>A | single nucleotide variant | Oocyte maturation defect 11 [RCV001787285] | Chr2:96132722 [GRCh38] Chr2:96798461 [GRCh37] Chr2:2q11.2 |
pathogenic |
NC_000002.11:g.(?_96780545)_(97475254_?)dup | duplication | not provided [RCV001981292] | Chr2:96780545..97475254 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2p25.1-q13(chr2:11504318-111365996)x1 | copy number loss | See cases [RCV002287563] | Chr2:11504318..111365996 [GRCh37] Chr2:2p25.1-q13 |
pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96628608-96981369)x3 | copy number gain | not provided [RCV002472784] | Chr2:96628608..96981369 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.902G>A (p.Ser301Asn) | single nucleotide variant | not specified [RCV004123718] | Chr2:96124244 [GRCh38] Chr2:96789983 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.151G>A (p.Gly51Arg) | single nucleotide variant | not specified [RCV004207628] | Chr2:96137605 [GRCh38] Chr2:96803344 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.475C>T (p.Arg159Cys) | single nucleotide variant | not specified [RCV004219822] | Chr2:96132702 [GRCh38] Chr2:96798441 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.628A>G (p.Ile210Val) | single nucleotide variant | not specified [RCV004074721] | Chr2:96132549 [GRCh38] Chr2:96798288 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.1018G>A (p.Gly340Arg) | single nucleotide variant | not specified [RCV004182170] | Chr2:96124128 [GRCh38] Chr2:96789867 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.925C>A (p.Leu309Met) | single nucleotide variant | not specified [RCV004204378] | Chr2:96124221 [GRCh38] Chr2:96789960 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.838G>A (p.Gly280Ser) | single nucleotide variant | not specified [RCV004192450] | Chr2:96129860 [GRCh38] Chr2:96795599 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.449T>C (p.Met150Thr) | single nucleotide variant | not specified [RCV004214584] | Chr2:96133431 [GRCh38] Chr2:96799170 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.625G>C (p.Glu209Gln) | single nucleotide variant | not specified [RCV004117454] | Chr2:96132552 [GRCh38] Chr2:96798291 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.167C>T (p.Pro56Leu) | single nucleotide variant | not specified [RCV004234480] | Chr2:96137589 [GRCh38] Chr2:96803328 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.953C>T (p.Ala318Val) | single nucleotide variant | not specified [RCV004234076] | Chr2:96124193 [GRCh38] Chr2:96789932 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.359T>C (p.Ile120Thr) | single nucleotide variant | not specified [RCV004159386] | Chr2:96133521 [GRCh38] Chr2:96799260 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.71C>T (p.Ala24Val) | single nucleotide variant | not specified [RCV004204633] | Chr2:96137685 [GRCh38] Chr2:96803424 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.950C>T (p.Ser317Leu) | single nucleotide variant | not specified [RCV004153174] | Chr2:96124196 [GRCh38] Chr2:96789935 [GRCh37] Chr2:2q11.2 |
likely benign |
NM_001002036.4(ASTL):c.159G>C (p.Lys53Asn) | single nucleotide variant | not specified [RCV004128187] | Chr2:96137597 [GRCh38] Chr2:96803336 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.821G>A (p.Arg274Gln) | single nucleotide variant | not specified [RCV004225850] | Chr2:96129877 [GRCh38] Chr2:96795616 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.235A>G (p.Ile79Val) | single nucleotide variant | not specified [RCV004279432] | Chr2:96135359 [GRCh38] Chr2:96801098 [GRCh37] Chr2:2q11.2 |
likely benign |
NM_001002036.4(ASTL):c.911C>T (p.Pro304Leu) | single nucleotide variant | not specified [RCV004252609] | Chr2:96124235 [GRCh38] Chr2:96789974 [GRCh37] Chr2:2q11.2 |
likely benign |
NM_001002036.4(ASTL):c.911C>A (p.Pro304Gln) | single nucleotide variant | not specified [RCV004280446] | Chr2:96124235 [GRCh38] Chr2:96789974 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.691G>A (p.Asp231Asn) | single nucleotide variant | not specified [RCV004352161] | Chr2:96130092 [GRCh38] Chr2:96795831 [GRCh37] Chr2:2q11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:96732520-99142320)x3 | copy number gain | not provided [RCV003484071] | Chr2:96732520..99142320 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:95773428-102550061)x3 | copy number gain | not provided [RCV003484069] | Chr2:95773428..102550061 [GRCh37] Chr2:2q11.1-11.2 |
likely pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96732520-97671333)x3 | copy number gain | not provided [RCV003484070] | Chr2:96732520..97671333 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
Single allele | deletion | not provided [RCV003448678] | Chr2:96555654..97769352 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.912G>A (p.Pro304=) | single nucleotide variant | not provided [RCV003427130] | Chr2:96124234 [GRCh38] Chr2:96789973 [GRCh37] Chr2:2q11.2 |
likely benign |
NM_001002036.4(ASTL):c.610C>T (p.Arg204Cys) | single nucleotide variant | not provided [RCV003427131] | Chr2:96132567 [GRCh38] Chr2:96798306 [GRCh37] Chr2:2q11.2 |
likely benign |
GRCh37/hg19 2q11.1-11.2(chr2:96735977-98212850)x3 | copy number gain | not specified [RCV003986352] | Chr2:96735977..98212850 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.1003G>A (p.Val335Ile) | single nucleotide variant | not specified [RCV004422926] | Chr2:96124143 [GRCh38] Chr2:96789882 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.340G>A (p.Glu114Lys) | single nucleotide variant | not specified [RCV004422929] | Chr2:96133540 [GRCh38] Chr2:96799279 [GRCh37] Chr2:2q11.2 |
likely benign |
NM_001002036.4(ASTL):c.70G>C (p.Ala24Pro) | single nucleotide variant | not specified [RCV004422932] | Chr2:96137686 [GRCh38] Chr2:96803425 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.89G>A (p.Cys30Tyr) | single nucleotide variant | not specified [RCV004422934] | Chr2:96137667 [GRCh38] Chr2:96803406 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.1036T>C (p.Trp346Arg) | single nucleotide variant | not specified [RCV004422927] | Chr2:96124110 [GRCh38] Chr2:96789849 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.530G>A (p.Arg177Gln) | single nucleotide variant | not specified [RCV004422931] | Chr2:96132647 [GRCh38] Chr2:96798386 [GRCh37] Chr2:2q11.2 |
uncertain significance |
Single allele | deletion | Pheochromocytoma [RCV003986083] | Chr2:96693904..96930791 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:96780545-98098961)x1 | copy number loss | not provided [RCV003885488] | Chr2:96780545..98098961 [GRCh37] Chr2:2q11.1-11.2 |
pathogenic |
NM_001002036.4(ASTL):c.10G>A (p.Val4Ile) | single nucleotide variant | not specified [RCV004422928] | Chr2:96138427 [GRCh38] Chr2:96804166 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.89G>T (p.Cys30Phe) | single nucleotide variant | not specified [RCV004672208] | Chr2:96137667 [GRCh38] Chr2:96803406 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.1042T>C (p.Ser348Pro) | single nucleotide variant | not specified [RCV004672220] | Chr2:96124104 [GRCh38] Chr2:96789843 [GRCh37] Chr2:2q11.2 |
likely benign |
NM_001002036.4(ASTL):c.773G>A (p.Ser258Asn) | single nucleotide variant | not specified [RCV004672228] | Chr2:96129925 [GRCh38] Chr2:96795664 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.402G>T (p.Arg134Ser) | single nucleotide variant | not specified [RCV004676583] | Chr2:96133478 [GRCh38] Chr2:96799217 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.669C>G (p.Ser223Arg) | single nucleotide variant | not specified [RCV004676580] | Chr2:96130114 [GRCh38] Chr2:96795853 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.1055A>G (p.Lys352Arg) | single nucleotide variant | not specified [RCV004672203] | Chr2:96124091 [GRCh38] Chr2:96789830 [GRCh37] Chr2:2q11.2 |
likely benign |
NM_001002036.4(ASTL):c.149C>G (p.Ser50Cys) | single nucleotide variant | not specified [RCV004856046] | Chr2:96137607 [GRCh38] Chr2:96803346 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.955G>A (p.Glu319Lys) | single nucleotide variant | not specified [RCV004856040] | Chr2:96124191 [GRCh38] Chr2:96789930 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.91G>A (p.Ala31Thr) | single nucleotide variant | not specified [RCV004856039] | Chr2:96137665 [GRCh38] Chr2:96803404 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.646A>G (p.Ile216Val) | single nucleotide variant | not specified [RCV004856036] | Chr2:96130137 [GRCh38] Chr2:96795876 [GRCh37] Chr2:2q11.2 |
uncertain significance |
GRCh38/hg38 2q11.2(chr2:96073560-97589743)x3 | copy number gain | See cases [RCV000143142] | Chr2:96073560..97589743 [GRCh38] Chr2:96739308..98206206 [GRCh37] Chr2:96103035..97572638 [NCBI36] Chr2:2q11.2 |
likely benign |
GRCh37/hg19 2q11.1-11.2(chr2:96544602-98118115)x1 | copy number loss | See cases [RCV000446002] | Chr2:96544602..98118115 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
GRCh37/hg19 2p25.3-q37.3(chr2:15672-243101834)x3 | copy number gain | not provided [RCV000752804] | Chr2:15672..243101834 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2q11.1-11.2(chr2:96544602-97706860)x3 | copy number gain | not provided [RCV001259643] | Chr2:96544602..97706860 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.49T>A (p.Leu17Met) | single nucleotide variant | not specified [RCV004361658] | Chr2:96138388 [GRCh38] Chr2:96804127 [GRCh37] Chr2:2q11.2 |
uncertain significance |
GRCh37/hg19 2q11.1-11.2(chr2:96555654-98024790)x1 | copy number loss | not provided [RCV004577457] | Chr2:96555654..98024790 [GRCh37] Chr2:2q11.1-11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.1235G>A (p.Ser412Asn) | single nucleotide variant | not specified [RCV004676556] | Chr2:96123911 [GRCh38] Chr2:96789650 [GRCh37] Chr2:2q11.2 |
uncertain significance |
NM_001002036.4(ASTL):c.973C>G (p.Pro325Ala) | single nucleotide variant | not specified [RCV004856021] | Chr2:96124173 [GRCh38] Chr2:96789912 [GRCh37] Chr2:2q11.2 |
uncertain significance |
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
The following QTLs overlap with this region. | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer | ![]() | Gviewer |
adipose tissue
|
alimentary part of gastrointestinal system
|
appendage
|
circulatory system
|
ectoderm
|
endocrine system
|
endoderm
|
exocrine system
|
hemolymphoid system
|
hepatobiliary system
|
integumental system
|
mesenchyme
|
mesoderm
|
musculoskeletal system
|
nervous system
|
renal system
|
reproductive system
|
respiratory system
|
sensory system
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1009 | 1714 | 2026 | 1484 | 4188 | 1045 | 1689 | 362 | 1858 | 225 | 2071 | 5316 | 4966 | 19 | 2960 | 631 | 1536 | 1225 | 145 |
Ensembl Acc Id: | ENST00000342380 ⟹ ENSP00000343674 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000470582 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001002036 ⟹ NP_001002036 | ||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | XM_011511205 ⟹ XP_011509507 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_011511207 ⟹ XP_011509509 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_011511208 ⟹ XP_011509510 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_054342125 ⟹ XP_054198100 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_054342126 ⟹ XP_054198101 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_054342127 ⟹ XP_054198102 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NP_001002036 ⟸ NM_001002036 |
- Peptide Label: | precursor |
- UniProtKB: | Q3KNT0 (UniProtKB/Swiss-Prot), Q6HA08 (UniProtKB/Swiss-Prot), Q3B826 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | XP_011509509 ⟸ XM_011511207 |
- Peptide Label: | isoform X2 |
- UniProtKB: | Q3B826 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | XP_011509507 ⟸ XM_011511205 |
- Peptide Label: | isoform X1 |
- UniProtKB: | Q3B826 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | XP_011509510 ⟸ XM_011511208 |
- Peptide Label: | isoform X3 |
- Sequence: |
Ensembl Acc Id: | ENSP00000343674 ⟸ ENST00000342380 |
RefSeq Acc Id: | XP_054198102 ⟸ XM_054342127 |
- Peptide Label: | isoform X3 |
RefSeq Acc Id: | XP_054198101 ⟸ XM_054342126 |
- Peptide Label: | isoform X2 |
- UniProtKB: | Q3B826 (UniProtKB/TrEMBL) |
RefSeq Acc Id: | XP_054198100 ⟸ XM_054342125 |
- Peptide Label: | isoform X1 |
- UniProtKB: | Q3B826 (UniProtKB/TrEMBL) |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q6HA08-F1-model_v2 | AlphaFold | Q6HA08 | 1-431 | view protein structure |
RGD ID: | 6796821 | ||||||||
Promoter ID: | HG_KWN:33915 | ||||||||
Type: | Non-CpG | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_2Hour, HeLa_S3, K562, Lymphoblastoid | ||||||||
Transcripts: | OTTHUMT00000338802 | ||||||||
Position: |
|
RGD ID: | 6796820 | ||||||||
Promoter ID: | HG_KWN:33916 | ||||||||
Type: | Non-CpG | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, HeLa_S3, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | NM_001002036 | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:31704 | AgrOrtholog |
COSMIC | ASTL | COSMIC |
Ensembl Genes | ENSG00000188886 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Transcript | ENST00000342380 | ENTREZGENE |
ENST00000342380.3 | UniProtKB/Swiss-Prot | |
Gene3D-CATH | 3.40.390.10 | UniProtKB/Swiss-Prot |
GTEx | ENSG00000188886 | GTEx |
HGNC ID | HGNC:31704 | ENTREZGENE |
Human Proteome Map | ASTL | Human Proteome Map |
InterPro | MetalloPept_cat_dom_sf | UniProtKB/Swiss-Prot |
Peptidase_M12A | UniProtKB/Swiss-Prot | |
Peptidase_Metallo | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:431705 | UniProtKB/Swiss-Prot |
NCBI Gene | 431705 | ENTREZGENE |
OMIM | 608860 | OMIM |
PANTHER | ASTACIN-LIKE METALLOENDOPEPTIDASE | UniProtKB/Swiss-Prot |
DISCOIDIN, CUB, EGF, LAMININ , AND ZINC METALLOPROTEASE DOMAIN CONTAINING | UniProtKB/Swiss-Prot | |
Pfam | Astacin | UniProtKB/Swiss-Prot |
PharmGKB | PA134922299 | PharmGKB |
PRINTS | ASTACIN | UniProtKB/Swiss-Prot |
PROSITE | ASTACIN | UniProtKB/Swiss-Prot |
ZINC_PROTEASE | UniProtKB/Swiss-Prot | |
SMART | ZnMc | UniProtKB/Swiss-Prot |
Superfamily-SCOP | Metalloproteases ('zincins'), catalytic domain | UniProtKB/Swiss-Prot |
UniProt | ASTL_HUMAN | UniProtKB/Swiss-Prot |
Q3B826 | ENTREZGENE, UniProtKB/TrEMBL | |
Q3KNT0 | ENTREZGENE | |
Q6HA08 | ENTREZGENE | |
UniProt Secondary | Q3KNT0 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2016-08-16 | ASTL | astacin like metalloendopeptidase | astacin-like metallo-endopeptidase (M12 family) | Symbol and/or name change | 5135510 | APPROVED |